Home

MICHAEL J COYLE

CIK 1233311 · President and CEO · last filed 2026-07-28

MICHAEL J COYLE is a President and CEO who has filed 89 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for HAE, was dated Jul 28, 2026. Across all open-market trades the lifetime net is −$46.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $22.8M across reported positions. 21 SEC filings were submitted jointly with Medtronic plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.83M

Companies

7

Total Filings

89

Lifetime Open-Market Net

-$46.08M

Filer Profile

Reported Address
125 SUMMER ST.
BOSTON, MA 02110
Related Filers
Medtronic plc — 21 joint filings, latest 2020-11-05
MEDTRONIC INC — 14 joint filings, latest 2015-01-28
GREATBATCH, INC. — 3 joint filings, latest 2026-05-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HAE Director 17,932 $105.40 $1.89M $0 8 2026-07-28
ITGR Director 3,322 $126.31 $419.6K $0 2 2026-05-22
IRTC President and CEO 33,247 $110.19 $3.66M $0 1 2021-02-26
MDT EVP & Group Pres, Cardiac&Vasc 190,640 $88.42 $16.86M -$22.56M 33 2020-11-05
Volcano Corp (VOLC) Delisted Director — — — $0 6 2012-05-24
VNUS MEDICAL TECHNOLOGIES INC (VNUS) Delisted Director 5,000 — — $0 12 2009-06-18
ST JUDE MEDICAL, LLC (STJ) Delisted President, CRMD 84,826 — — -$23.52M 27 2007-06-22

Recent Filings

89 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-28 HAE Grant (A) +2,538 $0 EDGAR
2026-05-22 ITGR Grant (A) +1,967 $0 EDGAR
2025-07-25 HAE Grant (A) +2,693 $0 EDGAR
2025-07-14 ITGR Grant (A) +1,355 $0 EDGAR
2024-07-26 HAE Grant (A) +2,207 $0 EDGAR
2023-08-08 HAE Grant (A) +2,226 $0 EDGAR
2022-08-08 HAE Grant (A) +2,730 $0 EDGAR
2021-08-09 HAE Grant (A) +3,077 $0 EDGAR
2021-02-26 IRTC Grant (A) +33,247 $0 EDGAR
2020-11-05 MDT Tax (F) −393 -$40.5K EDGAR
Showing 1–10 of 89
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.